Search

Learn why over 5,000 people a year travel more than 150 miles to MSK for cancer care, including resources for the specific needs of traveling patients and their loved ones.

… Thursday, December 4, 2025 Majiel Baker faced a crucial decision when she was diagnosed with breast cancer after her very first mammogram at age 40. Where should she go for treatment? Who should she trust to heal her? Should she stay local, near her hometown of Clifton Park, New York? Or should she go

Descubra por qué más de 2000 personas viajan desde todo el país para recibir tratamiento contra el cáncer en Memorial Sloan Kettering cada año, incluidos los recursos para las necesidades específicas de los pacientes que viajan y sus seres queridos.

… Thursday, December 4, 2025 Majiel Baker enfrentó una decisión crucial cuando fue diagnosticada con cáncer de mama después de su primera mamografía a los 40 años. ¿A dónde debería ir para recibir tratamiento? ¿En quién debería confiar para sanar? ¿Debería quedarse cerca de casa, en Clifton Park, Nueva

The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor.

… Tuesday, November 28, 2023 Update: On November 27, 2023, the U.S. Food and Drug Administration approved nirogacestat (Ogsiveo™) for adults with desmoid tumors that cannot be treated with surgery alone. The approval was based on research led by investigators at Memorial Sloan Kettering Cancer Center.

Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack.

… Tuesday, May 8, 2012 Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack . The Center has contracted with the New York State Cancer Services Program (CSP) of Western Suffolk County to

A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute, and Roswell Park Comprehensive Cancer Center report in a new study.

… Wednesday, September 28, 2022 A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber

Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.

… Friday, October 18, 2013 Summary Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division. Emily Foley, a laboratory investigator in the Sloan Kettering Institute Cell Biology Program , studies the molecular mechanisms

Gerstner Sloan Kettering student Elizabeth Wasmuth has been awarded the Chairman’s Prize for her paper published in Nature in 2014, on which she was the first author.

… Monday, August 3, 2015 Gerstner Sloan Kettering student Elizabeth Wasmuth has been awarded the Chairman’s Prize for her first-author paper Structure of an Rrp6-RNA exosome complex bound to poly (A) RNA , published in Nature in 2014. Elizabeth is currently doing her research in the laboratory of Christopher

The American College of Surgeons recently designated Memorial Sloan Kettering Cancer Center (MSK) the first-ever Children’s Surgery Verification (CSV) Quality Improvement Program Level I Specialty Children’s Surgery Center in Oncology. The distinction recognizes MSK as a highly specialized hospital providing exceptional surgical care that matches children’s needs with optimal pediatric resources.

… Tuesday, May 16, 2023 The American College of Surgeons recently designated Memorial Sloan Kettering Cancer Center (MSK) the first-ever Children’s Surgery Verification (CSV) Quality Improvement Program Level I Specialty Children’s Surgery Center in Oncology. The distinction recognizes MSK as a highly

Memorial Sloan Kettering Cancer Center’s (MSK) Deputy Chief Nursing Officer, Kevin P. Browne, DNP, RN, CNS, CCRN, was named the recipient of the 2021 Firefighter Thomas Phelan Memorial Award by the Irish American Building Society (IABS).

… Thursday, September 30, 2021 Memorial Sloan Kettering Cancer Center’s (MSK) Deputy Chief Nursing Officer, Kevin P. Browne, DNP, RN, CNS, CCRN, was named the recipient of the 2021 Firefighter Thomas Phelan Memorial Award by the Irish American Building Society (IABS). The award, which recognizes courageous

An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.

… Monday, October 16, 2023 Immunotherapy drugs called  checkpoint inhibitors may prevent serious tumors from forming in some people with an increased risk of cancer due to a condition called  Lynch syndrome , according to new research published October 16, 2023, in Nature Medicine by Memorial Sloan Kettering